Edwards EVOQUE tricuspid delivery system receives updated labeling for valve functionality warnings
Edwards Lifesciences has updated the labeling for its EVOQUE tricuspid delivery system to include a warning about potential loss of device functionality during valve replacement procedures. This is a labeling change to help clinicians recognize and respond to compromised system performance. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Review the updated labeling for the EVOQUE tricuspid delivery system (REF:9850TDS) if you use or manage this device in a clinical setting
- Contact Edwards Lifesciences directly with questions about the labeling update or device functionality
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Edwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Illnesses reported
- None reported
- Manufactured in
- 1 Edwards Way, Irvine, CA, United States
- Classification
- Class II
- Recall number
- Z-2172-2026
In the FDA's words
- Description
- Edwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO Labeling update to provide warning if functionality of the valve replacement delivery system is compromised. All Lots/UDI:0690103D004EVD000V5 Distribution: Worldwide - US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Saudi Arabia, Germany, United Kingdom.
- Hazard
- Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.
More from Edwards Lifesciences
- Edwards Commander M delivery system recalled for balloon rupture risk
SeriousFDANov 2, 2026